Imiquimod therapy for molluscum contagiosum

Journal of Cutaneous Medicine and Surgery

Volumn 4, Issue 2, 2000, Pages 76-82

  Liota, Elizabeth ^a   Smith, Kathleen J ^a   Buckley, Ronald ^b   Menon, Padmen ^c   Skelton, Henry ^d  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Dermatol Serv Charleston Nav H   (United States)

^c NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^d LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYDROCORTISONE; IMIQUIMOD; TRIAMCINOLONE;

ADULT; ARTICLE; BACTERIAL SKIN DISEASE; CHILD; CLINICAL ARTICLE; CREAM; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG PENETRATION; EDEMA; GENITAL SYSTEM DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; MOLLUSCUM CONTAGIOSUM; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; SKIN INFLAMMATION; SKIN MANIFESTATION;

EID: 0034057171     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347540000400207     Document Type: Article

References (30)

1. Thompson CH, Yager JA, Van Rensburg IB. Close relationship between equine and human molluscum contagiosum virus demonstrated by in situ hybridisation. Res Vet Sci 1998; 64:157-161.
2. Gottleib SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol 1994; 33:453-461.
3. Epstein WL. Molluscum contagiosum. Semin Dermatol 1992; 11:184-189.
4. Lewis EJ, Larn M, Crutchfield CE. An update on molluscum contagiosum. Cutis 1997; 60:29-34.
5. Schwanz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27:583-588.
6. Porter CD, Blake NW, Carchard LC, et al. Molluscum contagiosum virus types in genital and non-genital lesions. Br J Dermatol 1989; 120:37-41.
7. Smith KJ, Skelton HG, Yeager J, et al. and the Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol 1994; 31:747-754.
8. Cronin T, Resnik B, Elgart G, et al. Recalcitrant giant molluscum contagiosum in a patient with AIDS. J Am Acad Dermatol 1996; 35:266-277.
9. Senkevich TG, Bugert JJ, Sisler JR, et al. Genome sequence of a human tumorigenic poxvirus: prediction of specific host responseevasion genes. Science 1996; 273:813-816.
10. Yamashita H, Uemura T, Kawashima M. Molecular epidemiologic analysis of Japanese patients with molluscum contagiosum. Int J Dermatol 1996; 35:99-105.
11. Mark R, Buller L, Burnett J, et al. Replication of molluscum contagiosum. Urology 1995; 213:655-659.
12. Nakamura J, Muraki Y, Yamada Y, et al. Analysis of molluscum contagiosum virus genomes isolated in Japan. J Med Virol 1995; 46:339-348.
13. Porter CD, Blake NW, Archard LC. Structure and activity of epidermal-growth-factor-like peptides: induction of basal cell proliferation by a poxvirus gene product? Biol Soc Trans 1988; 16:671-674.
14. Porter CD, Archard LC. Characterization and physical mapping of molluscum contagiosum virus DNA and location of a sequence capable of encoding a conserved domain of epidermal growth factor. J Gen Virol 1987; 68:673-682.
15. Meini E, Fickenscher H, Thome M, et al. Anti-apoptotic strategies of lymphotropic viruses. Immunol Today 1998; 19:474-479.
16. Kono MD, Kondo S, Shivji GM, et al. Effects of the immunomodulator R-837 on cytokine gene expression in the human epidermal carcinoma cell line COLO-16. Lymphokine Cytokine Res 1994; 13:71-76.
17. Fujisawa H, Sivji GM, Kondo S, et al. Effect of a novel topical immunomodulator S-28463 on keratinocyte cytokine gene expression and production. J Interferon Cytokine Res 1996; 16:555-559.
18. Imbertson LM, Beaurline JM, Couture AM, et al. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. J Invest Dermatol 1998; 110:734-739.
19. Sauder DN. The role of epidermal cytokines in inflammatory diseases. J Invest Dermatol 1990; 95:27S-28S.
20. Katz S. The skin as an immunologic organ: allergic contact dermatitis as a paradigm. J Invest Dermatol 1993; 20:593-603.
21. Schroder JM. Cytokine networks in the skin. J Invest Dermatol 1995; 1:20S-24S.
22. Parronchi P, De Carli M, Manetti R, et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by the Th1 and Th2 human T cell clones. J Immunol 1992; 149:2977-2983.
23. Finkelman FD, Svetic A, Gresser I, et al. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 1991; 174:1179-1188.
24. Gunzburg WH, Salmons B. Virus vector design in gene therapy. Mol Med Today 1995; 1:410-417.
25. Stewart WE II. The interferon system. New York: Springer Verlag, 1981.
26. Obrador E, Navarro J, Mompo J, et al. Regulation of tumour cell sensitivity to TNF-induced oxidative stress and cytotxicity: role of glutathione. Biofacts 1998; 8:23-26.
27. Schulze-Osthoff K, Ferrari D, Los M, et al. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254:439-459.
28. Kristal L, Clark RAF. Atopic dermatitis. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, eds. Cutaneous medicine and surgery. Philadelphia: WB Saunders, 1996:195-204.
29. Megyeri K, Au WC, Rosztoczy I, et al. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction. Mol Cell Biol 1995; 15:2207-2218.
30. Meadows K, Tyring S, Pavia A, et al. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 1997; 133:987-990.